Bevacizumab: all 1,786 studies that test it
Page 16 of 18. Open to participants first (285), then studies with results posted, then the rest; newest registration first within each.
- A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast CancerCompletedNCT00773695Phase 2
- A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent GlioblastomaCompletedNCT00762255Phase 1
- Doxil, Bevacizumab and Temsirolimus TrialCompletedNCT00761644Phase 1
- A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid TumorsCompletedNCT00756340Phase 1
- Metronomic Vinorelbine and Bevacizumab in Patients With Non Small Cell Lung CancerCompletedNCT00755170Phase 2
- Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung CancerWithdrawnNCT00755157Phase 2
- Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic CrcTerminatedNCT00755118Phase 2
- Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast CancerCompletedNCT00754351Phase 2
- Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung CancerCompletedNCT00753909Phase 2
- Combination of Erlotinib and Bevacizumab as Second-line Treatment in Patients With Non-small Cell Lung CancerTerminatedNCT00749567Phase 2
- Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD)Status unknownNCT00745511Phase 1/2
- Bevacizumab and Carboplatin for Patients With Ovarian CancerCompletedNCT00744718Phase 2
- Pemetrexed Plus Bevacizumab in Non Small Cell Lung CancerCompletedNCT00741221Phase 2
- Docetaxel Plus Bevacizumab in Metastatic Non Small Cell Lung CancerCompletedNCT00741195Phase 2
- Efficacy Study of Triamcinolone and Bevacizumab Intravitreal for Treatment of Diabetic Macular EdemaCompletedNCT00737971Phase 4
- FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal CarcinomaWithdrawnNCT00735241Phase 2/3
- Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00734890Phase 1
- Second-Line Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Who Have Received First-Line Chemotherapy and BevacizumabTerminatedNCT00720512Phase 3
- Irinotecan, Capecitabine and Avastin for Metastatic Colorectal Cancer as Salvage TreatmentTerminatedNCT00717990Phase 2
- Study to Assess Safety & Tolerability of AZD2281 in Combination With Bevacizumab in Patients With Advanced Solid TumoursCompletedNCT00710268Phase 1
- Manta Study: Avastin Versus Lucentis in Age Related Macular DegenerationStatus unknownNCT00710229Phase 3
- Early Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer PatientsCompletedNCT00708448Phase 1
- Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal CancerCompletedNCT00707889Phase 2
- Docetaxel/Epirubicin/Bevacizumab as First Line Therapy for Metastatic HER2 Negative Breast CancerCompletedNCT00705315Phase 1/2
- Intravitreal Bevacizumab for Diabetic Macular EdemaStatus unknownNCT00703235Phase 2/3
- Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic TherapyCompletedNCT00702975Phase 2
- Pan-VEGF Blockade for the Treatment of Retinopathy of PrematurityTerminatedNCT00702819Phase 1
- Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung CancerTerminatedNCT00702572Phase 1
- Photodynamic Therapy Combined With Bevacizumab vs Bevacizumab Alone for Neovascular Age-related Macular DegenerationWithdrawnNCT00696592Phase 2
- Vinorelbine Metronomic Plus Bevacizumab as Salvage Therapy for Breast CancerTerminatedNCT00694200Phase 2
- Weekly Paclitaxel/Carboplatin/Bevacizumab as First Line Therapy for Triple Negative Breast CancerCompletedNCT00691379Phase 1/2
- Pars Plana Vitrectomy (PPV) Versus Preoperative Intravitreal Bevacizumab Plus PPV to Treat Diabetic Tractional Retinal Detachment (IBETRA)CompletedNCT00690768Phase 2
- Intravitreal Bevacizumab Combined With PDT Versus Bevacizumab to Treat Exudative AMDStatus unknownNCT00684853Phase 2
- Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal CancerTerminatedNCT00681876Phase 2
- Intravitreal Injection of Bevacizumab and Gas for Diabetic Premacular Hemorrhage With Active Fibrovascular ProliferationStatus unknownNCT00673296Not applicable
- Preoperative Combined RadioChemo-Molecular Target Therapy With Capecitabine, Bevacizumab, and RadiotherapyTerminatedNCT00671645Phase 2
- A Study of Dulanermin Administered in Combination With Camptosar®/Erbitux® Chemotherapy or FOLFIRI (With or Without Bevacizumab) in Subjects With Previously Treated Metastatic Colorectal CancerCompletedNCT00671372Phase 1
- Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and LeukemiaCompletedNCT00665990Phase 1
- Neo-adjuvant Therapy and the Effect on Synchronous Metastatic GrowthStatus unknownNCT00659022Phase 2
- Bevacizumab and Long Acting Gas in Diabetic VitrectomyCompletedNCT00656435Phase 3
- Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian OriginStatus unknownNCT00652119Phase 1
- Mesothelioma Avastin Plus Pemetrexed-cisplatin StudyCompletedNCT00651456Phase 2/3
- A Genetic Substudy Associated With the Avastin (Bevacizumab) Study MO19390 in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.TerminatedNCT00642824Phase 2
- The Effects of Bevacizumab and Ranibizumab on Ocular Pulse Amplitude in Neovascular Age Related Macular Degeneration (AMD)Status unknownNCT00640640Not applicable
- Study of Cetuximab and Bevacizumab in Cancer of the Esophagus After Failure of Patient's First TherapyWithdrawnNCT00636298Phase 2
- Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal CancerCompletedNCT00628810Phase 2
- BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus BevacizumabTerminatedNCT00625898Phase 3
- Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell CarcinomaCompletedNCT00619268Phase 2
- Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic CancerCompletedNCT00614653Phase 1
- PTK787/ZK222584 With Bevacizumab in Patients With Refractory and/or Advanced MalignanciesCompletedNCT00611793Phase 1
- Bevacizumab and Temsirolimus in Patients With Advanced MalignancyCompletedNCT00610493Phase 1
- Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250CompletedNCT00602862Not applicable
- Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic CancerCompletedNCT00602602Phase 2
- MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal CancerTerminatedNCT00602329Phase 2
- Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control StudyWithdrawnNCT00600301Phase 3
- Intravitreal Bevacizumab for Diabetic RetinopathyTerminatedNCT00600262Phase 2/3
- Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix CancerWithdrawnNCT00600210Phase 2
- Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid StreaksTerminatedNCT00599820Phase 3
- Preoperative Bevacizumab for Vitreous HemorrhageCompletedNCT00596297Phase 1/2
- BEP Study Phase I (Bevacizumab, Everolimus, Panitumumab)CompletedNCT00586443Phase 1
- A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid TumorsCompletedNCT00586092Phase 1
- Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung CancerCompletedNCT00578149Phase 2
- Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate CancerCompletedNCT00574769Phase 1/2
- Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal CancerCompletedNCT00569790Phase 2
- Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC)CompletedNCT00569699Phase 2
- Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal CancerCompletedNCT00569335Phase 2
- Temozolomide and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By SurgeryCompletedNCT00568048Phase 2
- POSTERIOR SUB-TENON'S AvastinWithdrawnNCT00567372Phase 4
- Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVOTerminatedNCT00566761Phase 4
- A Trial of Bevacizumab in Myelodysplastic Syndromes (Int-1, Int-2 and High Risk According to International Prognostic Scoring System (IPSS)) With Excess of Marrow BlastsTerminatedNCT00565656Phase 2
- Intravitreal Avastin in Proliferative RetinopathiesCompletedNCT00564148Phase 2
- Prevention of Vision Loss in Patients With Age-Related Macular Degeneration (AMD) by Intravitreal Injection of Bevacizumab and RanibizumabStatus unknownNCT00559715Phase 3
- XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal AdenocarcinomaStatus unknownNCT00557713Phase 2
- Intraocular Bevacizumab (Avastin) for Rubeosis IridisCompletedNCT00557232Phase 4
- Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular DegenerationCompletedNCT00556348Phase 4
- LBH589, Paclitaxel, Carboplatin +/- Bevacizumab for Solid TumorsCompletedNCT00556088Phase 1
- Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal NeovascularizationCompletedNCT00555594Phase 2/3
- Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic CancerCompletedNCT00550927Phase 1
- Bevacizumab Versus Ranibizumab for Diabetic RetinopathyCompletedNCT00545870Phase 3
- Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal CancerTerminatedNCT00544700Phase 3
- Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal CancerStatus unknownNCT00544011Phase 2
- Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal CancerCompletedNCT00543842Phase 1
- G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal CancerCompletedNCT00541125Phase 2
- Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant MelanomaStatus unknownNCT00538005Phase 1/2
- First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International StudyCompletedNCT00537901Not applicable
- BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00533585Phase 1
- Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal CancerCompletedNCT00532909Phase 1
- MAAM Study: Avastin and Macugen Versus Avastin Versus MacugenCompletedNCT00531336Phase 2
- Safety Study of Bevacizumab (Avastin) With Thoracic Radiation in Non-small Cell Cell Lung CancerTerminatedNCT00531076Phase 1
- Systemic Avastin Therapy in Age-Related Macular DegenerationCompletedNCT00531024Phase 2/3
- Valproic Acid and Bevacizumab in Patients With Advanced CancerCompletedNCT00530907Phase 1
- Effect of Intravitreal Bevacizumab on Early Post-Vitrectomy Hemorrhage in Diabetic PatientsStatus unknownNCT00524875Not applicable
- Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By SurgeryWithdrawnNCT00524069Not applicable
- Corneal Thinning During Topical Bevacizumab TherapyWithdrawnNCT00515684Not applicable
- Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by SurgeryStatus unknownNCT00513266Phase 2
- Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer PatientsCompletedNCT00511459Phase 2
- A Study of AMG 951 [rhApo2L/TRAIL] in Subjects With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy +/- BevacizumabCompletedNCT00508625Phase 2
- Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and AvastinCompletedNCT00507585Phase 1
- A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g)CompletedNCT00497497Phase 1
- Unilateral Bevacizumab for Bilateral Diabetic Macular EdemaWithdrawnNCT00496405Phase 4